The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
An oral prostate cancer RIPTAC therapeutic in phase 1 for metastatic castrate resistant prostate cancer (mCRPC).
 
Katherine Kayser-Bricker
Employment - Halda Therapeutics
Leadership - Halda Therapeutics; Modifi Bio
Stock and Other Ownership Interests - Halda Therapeutics; Modifi Bio
Research Funding - Halda Therapeutics
Patents, Royalties, Other Intellectual Property - Halda Therapeutics
 
Andrew Armstrong
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; Bristol-Myers Squibb; Cytogen; Exelixis; GoodRx; Janssen; Merck; Myovant Sciences; Novartis; Pfizer
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Bristol-Myers Squibb (Inst); Janssen Oncology (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Syntrix Biosystems (Inst)
Patents, Royalties, Other Intellectual Property - Circulating tumor cell novel capture technology (Inst)
Travel, Accommodations, Expenses - Astellas Scientific and Medical Affairs Inc
 
Johann De Bono
Honoraria - Amgen; Astellas Pharma; AstraZeneca; Bayer; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; ImCheck therapeutics; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; Pfizer; Sanofi
Consulting or Advisory Role - Abbvie; Acai Therapeutics; Amgen; Amunix (Inst); Astellas Pharma; AstraZeneca; Bayer; BioXCel therapeutics (Inst); Boehringer Ingelheim (Inst); CellCentric; Crescendo Biologics (Inst); Daiichi Sankyo; Dark Blue Therapeutics (Inst); Eisai; Genentech/Roche; Genmab; GlaxoSmithKline; Harpoon therapeutics; ImCheck therapeutics; Immunic Therapeutics; Janssen Oncology; Merck Serono; Merck Sharp & Dohme; MetaCurUm; Myricx Pharma; Novartis; Nurix (Inst); Oncternal Therapeutics; Orion; Pfizer (Inst); Qiagen; Sanofi Aventis GmbH (Inst); Sierra Oncology; Taiho Oncology; Takeda (Inst); Tango Therapeutics (Inst)
Speakers' Bureau - AstraZeneca
Research Funding - Amgen (Inst); AstraZeneca (Inst); CellCentric (Inst); Crescendo Biologics (Inst); Daiichi Sankyo (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Immunic Therapeutics (Inst); Janssen (Inst); Merck Serono (Inst); Merck Sharp & Dohme (Inst); MetaCurUm (Inst); MorphoSys (Inst); Myricx (Inst); Nurix (Inst); Oncternal Therapeutics (Inst); Orion (Inst); Pfizer (Inst); Sanofi Aventis GmbH (Inst); Taiho Pharmaceutical (Inst)
Patents, Royalties, Other Intellectual Property - Abiraterone Rewards to Inventors (Inst); CHK1 inhibitor (Inst); PARP inhibitors and DNA repair defects (Inst); Targeting of IL23 in prostate cancer (Inst)
Travel, Accommodations, Expenses - Amgen; Astellas Pharma; AstraZeneca; Bayer; Cellcentric; Daiichi Sankyo; Genentech/Roche; GlaxoSmithKline; Halda Therapeutics; Merck Serono; Merck Sharp & Dohme; Orion; Pfizer; Sanofi
 
Xin Gao
Consulting or Advisory Role - Abeona Therapeutics; ADC Therapeutics; Arvinas; Bayer; Flare Therapeutics; Hinova Pharmaceuticals; Loxo/Lilly
Research Funding - ALX Oncology (Inst); Aprea Therapeutics (Inst); Aravive (Inst); Arvinas (Inst); Bayer (Inst); Exelixis (Inst); Harpoon therapeutics (Inst); Loxo/Lilly (Inst); Merck (Inst); Novartis (Inst); Nuvation Bio (Inst); Pfizer (Inst); Poseida therapeutics (Inst); Regeneron (Inst); Takeda (Inst); TopAlliance BioSciences Inc (Inst)
 
Joseph Kim
Consulting or Advisory Role - Halda Therapeutics; Janssen Biotech
Research Funding - Abbvie (Inst); Acrivon Therapeutics (Inst); ADC Therapeutics (Inst); Antengene (Inst); AstraZeneca (Inst); Cosmo Pharmaceuticals; Dendreon (Inst); Exelixis (Inst); Hummingbird (Inst); IgM Biosciences (Inst); Janux Therapeutics (Inst); Regeneron (Inst); Roche (Inst)
 
Michael Morris
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Ambrx; Amgen; Arvinas; Blue Earth Diagnostics; Bristol-Myers Squibb/Celgene; Clarity Pharmaceuticals; Convergent Therapeutics; Core Medica; Curium Pharma; Daiichi; Exelixis; Flare Therapeutics; Fusion Pharmaceuticals; ITM Isotope Technologies Munich; Lantheus Medical Imaging; Mashup Media; Pfizer; POINT Biopharma; Progenics; Telix Pharmaceuticals; Transtherabio; Z-Alpha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; APCCC; AstraZeneca; Memorial Sloan-Kettering Cancer Center
(OPTIONAL) Uncompensated Relationships - Amgen; Bayer; Halda Therapeutics; Janssen Oncology; Novartis; Wren Laboraties
 
Matthew Smith
Consulting or Advisory Role - Ambrx; Amgen; Astellas Pharma; Bayer; Janssen Oncology; Lilly; Novartis; Oncternal Therapeutics; Pfizer
Research Funding - Bayer (Inst); ESSA (Inst); Janssen Oncology (Inst); Lilly (Inst); ORIC Pharmaceuticals (Inst)
Expert Testimony - Janssen Oncology; Novartis
 
Kanak Raina
Employment - Halda Therapeutics
Stock and Other Ownership Interests - Arvinas; Crispr Therapeutics; Halda Therapeutics; IDEAYA Biosciences; Intellia Therapeutics; Revolution Medicines
Consulting or Advisory Role - Firefly Bio
Research Funding - Halda Therapeutics
Patents, Royalties, Other Intellectual Property - Halda Therapeutics
 
Aaron (Ron) Weitzman
Leadership - Tango Therapeutics
Stock and Other Ownership Interests - Halda Therapeutics; Sensei Biotherapeutics
Consulting or Advisory Role - Frontier Medicines; Halda Therapeutics; Osmol Therapeutics; Zentalis
Travel, Accommodations, Expenses - Sensei Biotherapeutics
 
Hope Meely
Employment - Halda Therapeutics; Slope.io
Leadership - Halda Therapeutics; Slope.io
Stock and Other Ownership Interests - Halda Therapeutics; Slope.io
Research Funding - Halda Therapeutics; Slope.io
 
Paul Ehrlich
Stock and Other Ownership Interests - Alphina Therapeutics; Halda Therapeutics
Consulting or Advisory Role - Alphina Therapeutics; Attivare Therapeutics; Halda Therapeutics; Vironexis Therapeutics
Travel, Accommodations, Expenses - Alphina Therapeutics; Halda Therapeutics
 
Katherine Kacena
Consulting or Advisory Role - StrandTx
 
Peter Rix
Employment - Quivive Pharma, Inc
Leadership - Quivive Pharma, Inc.
Stock and Other Ownership Interests - Halda Therapeutics; Quivive Pharma, Inc.
Consulting or Advisory Role - Halda Therapeutics
 
Kyle Eastman
Employment - Halda Therapeutics
Stock and Other Ownership Interests - Halda Therapeutics
Research Funding - Halda Therapeutics
Patents, Royalties, Other Intellectual Property - Halda Therapeutics
Other Relationship - Kapis Bio
 
James Mousseau
Employment - Halda Therapeutics
Stock and Other Ownership Interests - Halda Therapeutics
Research Funding - Halda Therapeutics
Patents, Royalties, Other Intellectual Property - Halda Therapeutics
 
Matthew Perry
Employment - Halda Therapeutics
Stock and Other Ownership Interests - Halda Therapeutics
Research Funding - Halda Therapeutics
Patents, Royalties, Other Intellectual Property - Halda Therapeutics; Reactive Biosciences